Global Follicular Lymphoma Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jan-2021
No. of pages: 129
Inquire Before Buying

Follicular Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Follicular Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Chemotherapy

- Radiotherapy

- Monoclonal Antibodies

- Stem Cell Transplantation

Segment by Application

- Hospital

- Clinic

- Others

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Boehringer Ingelheim GmbH

- Bristol-Myers Squibb Company

- Celgene Corporation

- Celldex Therapeutics, Inc.

- Celltrion, Inc.

- Cellular Biomedicine Group, Inc.

- Coherus BioSciences, Inc.

- CTI BioPharma Corp.

- Curis, Inc.

- Celldex Therapeutics, Inc.

- Celltrion, Inc.

- EpiZyme, Inc.

- F. Hoffmann-La Roche Ltd.

- Genentech, Inc.

- Gilead Sciences, Inc.

- GlaxoSmithKline Plc

- Hutchison MediPharma Limited

- Immune Design Corp.

Global Follicular Lymphoma Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Follicular Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiotherapy
1.2.4 Monoclonal Antibodies
1.2.5 Stem Cell Transplantation
1.3 Market by Application
1.3.1 Global Follicular Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Follicular Lymphoma Treatment Market Perspective (2016-2027)
2.2 Follicular Lymphoma Treatment Growth Trends by Regions
2.2.1 Follicular Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Follicular Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Follicular Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Follicular Lymphoma Treatment Industry Dynamic
2.3.1 Follicular Lymphoma Treatment Market Trends
2.3.2 Follicular Lymphoma Treatment Market Drivers
2.3.3 Follicular Lymphoma Treatment Market Challenges
2.3.4 Follicular Lymphoma Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Follicular Lymphoma Treatment Players by Revenue
3.1.1 Global Top Follicular Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Follicular Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Follicular Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Follicular Lymphoma Treatment Revenue
3.4 Global Follicular Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Follicular Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Follicular Lymphoma Treatment Revenue in 2020
3.5 Follicular Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Follicular Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Follicular Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Follicular Lymphoma Treatment Breakdown Data by Type
4.1 Global Follicular Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2022-2027)
5 Follicular Lymphoma Treatment Breakdown Data by Application
5.1 Global Follicular Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Follicular Lymphoma Treatment Market Size (2016-2027)
6.2 North America Follicular Lymphoma Treatment Market Size by Type
6.2.1 North America Follicular Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Follicular Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Follicular Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Follicular Lymphoma Treatment Market Size by Application
6.3.1 North America Follicular Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Follicular Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Follicular Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Follicular Lymphoma Treatment Market Size by Country
6.4.1 North America Follicular Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Follicular Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Follicular Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Follicular Lymphoma Treatment Market Size by Type
7.2.1 Europe Follicular Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Follicular Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Follicular Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Follicular Lymphoma Treatment Market Size by Application
7.3.1 Europe Follicular Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Follicular Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Follicular Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Follicular Lymphoma Treatment Market Size by Country
7.4.1 Europe Follicular Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Follicular Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Follicular Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Follicular Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Follicular Lymphoma Treatment Market Size by Type
9.2.1 Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Follicular Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Follicular Lymphoma Treatment Market Size by Application
9.3.1 Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Follicular Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Follicular Lymphoma Treatment Market Size by Country
9.4.1 Latin America Follicular Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Follicular Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Follicular Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim GmbH
11.1.1 Boehringer Ingelheim GmbH Company Details
11.1.2 Boehringer Ingelheim GmbH Business Overview
11.1.3 Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Introduction
11.1.4 Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.1.5 Boehringer Ingelheim GmbH Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Follicular Lymphoma Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Celgene Corporation
11.3.1 Celgene Corporation Company Details
11.3.2 Celgene Corporation Business Overview
11.3.3 Celgene Corporation Follicular Lymphoma Treatment Introduction
11.3.4 Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.3.5 Celgene Corporation Recent Development
11.4 Celldex Therapeutics, Inc.
11.4.1 Celldex Therapeutics, Inc. Company Details
11.4.2 Celldex Therapeutics, Inc. Business Overview
11.4.3 Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Introduction
11.4.4 Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.4.5 Celldex Therapeutics, Inc. Recent Development
11.5 Celltrion, Inc.
11.5.1 Celltrion, Inc. Company Details
11.5.2 Celltrion, Inc. Business Overview
11.5.3 Celltrion, Inc. Follicular Lymphoma Treatment Introduction
11.5.4 Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.5.5 Celltrion, Inc. Recent Development
11.6 Cellular Biomedicine Group, Inc.
11.6.1 Cellular Biomedicine Group, Inc. Company Details
11.6.2 Cellular Biomedicine Group, Inc. Business Overview
11.6.3 Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Introduction
11.6.4 Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.6.5 Cellular Biomedicine Group, Inc. Recent Development
11.7 Coherus BioSciences, Inc.
11.7.1 Coherus BioSciences, Inc. Company Details
11.7.2 Coherus BioSciences, Inc. Business Overview
11.7.3 Coherus BioSciences, Inc. Follicular Lymphoma Treatment Introduction
11.7.4 Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.7.5 Coherus BioSciences, Inc. Recent Development
11.8 CTI BioPharma Corp.
11.8.1 CTI BioPharma Corp. Company Details
11.8.2 CTI BioPharma Corp. Business Overview
11.8.3 CTI BioPharma Corp. Follicular Lymphoma Treatment Introduction
11.8.4 CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.8.5 CTI BioPharma Corp. Recent Development
11.9 Curis, Inc.
11.9.1 Curis, Inc. Company Details
11.9.2 Curis, Inc. Business Overview
11.9.3 Curis, Inc. Follicular Lymphoma Treatment Introduction
11.9.4 Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.9.5 Curis, Inc. Recent Development
11.10 Dynavax Technologies Corporation
11.10.1 Dynavax Technologies Corporation Company Details
11.10.2 Dynavax Technologies Corporation Business Overview
11.10.3 Dynavax Technologies Corporation Follicular Lymphoma Treatment Introduction
11.10.4 Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.10.5 Dynavax Technologies Corporation Recent Development
11.11 Eisai
11.11.1 Eisai Company Details
11.11.2 Eisai Business Overview
11.11.3 Eisai Follicular Lymphoma Treatment Introduction
11.11.4 Eisai Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.11.5 Eisai Recent Development
11.12 EpiZyme, Inc.
11.12.1 EpiZyme, Inc. Company Details
11.12.2 EpiZyme, Inc. Business Overview
11.12.3 EpiZyme, Inc. Follicular Lymphoma Treatment Introduction
11.12.4 EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.12.5 EpiZyme, Inc. Recent Development
11.13 F. Hoffmann-La Roche Ltd.
11.13.1 F. Hoffmann-La Roche Ltd. Company Details
11.13.2 F. Hoffmann-La Roche Ltd. Business Overview
11.13.3 F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Introduction
11.13.4 F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.13.5 F. Hoffmann-La Roche Ltd. Recent Development
11.14 Genentech, Inc.
11.14.1 Genentech, Inc. Company Details
11.14.2 Genentech, Inc. Business Overview
11.14.3 Genentech, Inc. Follicular Lymphoma Treatment Introduction
11.14.4 Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.14.5 Genentech, Inc. Recent Development
11.15 Gilead Sciences, Inc.
11.15.1 Gilead Sciences, Inc. Company Details
11.15.2 Gilead Sciences, Inc. Business Overview
11.15.3 Gilead Sciences, Inc. Follicular Lymphoma Treatment Introduction
11.15.4 Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.15.5 Gilead Sciences, Inc. Recent Development
11.16 GlaxoSmithKline Plc
11.16.1 GlaxoSmithKline Plc Company Details
11.16.2 GlaxoSmithKline Plc Business Overview
11.16.3 GlaxoSmithKline Plc Follicular Lymphoma Treatment Introduction
11.16.4 GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.16.5 GlaxoSmithKline Plc Recent Development
11.17 Hutchison MediPharma Limited
11.17.1 Hutchison MediPharma Limited Company Details
11.17.2 Hutchison MediPharma Limited Business Overview
11.17.3 Hutchison MediPharma Limited Follicular Lymphoma Treatment Introduction
11.17.4 Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.17.5 Hutchison MediPharma Limited Recent Development
11.18 Immune Design Corp.
11.18.1 Immune Design Corp. Company Details
11.18.2 Immune Design Corp. Business Overview
11.18.3 Immune Design Corp. Follicular Lymphoma Treatment Introduction
11.18.4 Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
11.18.5 Immune Design Corp. Recent Development
11.18 ImmunoGen, Inc.
.1 ImmunoGen, Inc. Company Details
.2 ImmunoGen, Inc. Business Overview
.3 ImmunoGen, Inc. Follicular Lymphoma Treatment Introduction
.4 ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021)
.5 ImmunoGen, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Follicular Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Monoclonal Antibodies
Table 5. Key Players of Stem Cell Transplantation
Table 6. Global Follicular Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Follicular Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Follicular Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Follicular Lymphoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Follicular Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Follicular Lymphoma Treatment Market Share by Regions (2022-2027)
Table 12. Follicular Lymphoma Treatment Market Trends
Table 13. Follicular Lymphoma Treatment Market Drivers
Table 14. Follicular Lymphoma Treatment Market Challenges
Table 15. Follicular Lymphoma Treatment Market Restraints
Table 16. Global Follicular Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Follicular Lymphoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2020)
Table 19. Ranking of Global Top Follicular Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Follicular Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Follicular Lymphoma Treatment Product Solution and Service
Table 23. Date of Enter into Follicular Lymphoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Follicular Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Follicular Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Follicular Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Follicular Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Follicular Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Follicular Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Follicular Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Follicular Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Boehringer Ingelheim GmbH Company Details
Table 64. Boehringer Ingelheim GmbH Business Overview
Table 65. Boehringer Ingelheim GmbH Follicular Lymphoma Treatment Product
Table 66. Boehringer Ingelheim GmbH Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 67. Boehringer Ingelheim GmbH Recent Development
Table 68. Bristol-Myers Squibb Company Company Details
Table 69. Bristol-Myers Squibb Company Business Overview
Table 70. Bristol-Myers Squibb Company Follicular Lymphoma Treatment Product
Table 71. Bristol-Myers Squibb Company Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Bristol-Myers Squibb Company Recent Development
Table 73. Celgene Corporation Company Details
Table 74. Celgene Corporation Business Overview
Table 75. Celgene Corporation Follicular Lymphoma Treatment Product
Table 76. Celgene Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Celgene Corporation Recent Development
Table 78. Celldex Therapeutics, Inc. Company Details
Table 79. Celldex Therapeutics, Inc. Business Overview
Table 80. Celldex Therapeutics, Inc. Follicular Lymphoma Treatment Product
Table 81. Celldex Therapeutics, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 82. Celldex Therapeutics, Inc. Recent Development
Table 83. Celltrion, Inc. Company Details
Table 84. Celltrion, Inc. Business Overview
Table 85. Celltrion, Inc. Follicular Lymphoma Treatment Product
Table 86. Celltrion, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 87. Celltrion, Inc. Recent Development
Table 88. Cellular Biomedicine Group, Inc. Company Details
Table 89. Cellular Biomedicine Group, Inc. Business Overview
Table 90. Cellular Biomedicine Group, Inc. Follicular Lymphoma Treatment Product
Table 91. Cellular Biomedicine Group, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Cellular Biomedicine Group, Inc. Recent Development
Table 93. Coherus BioSciences, Inc. Company Details
Table 94. Coherus BioSciences, Inc. Business Overview
Table 95. Coherus BioSciences, Inc. Follicular Lymphoma Treatment Product
Table 96. Coherus BioSciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Coherus BioSciences, Inc. Recent Development
Table 98. CTI BioPharma Corp. Company Details
Table 99. CTI BioPharma Corp. Business Overview
Table 100. CTI BioPharma Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. CTI BioPharma Corp. Recent Development
Table 102. Curis, Inc. Company Details
Table 103. Curis, Inc. Business Overview
Table 104. Curis, Inc. Follicular Lymphoma Treatment Product
Table 105. Curis, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Curis, Inc. Recent Development
Table 107. Dynavax Technologies Corporation Company Details
Table 108. Dynavax Technologies Corporation Business Overview
Table 109. Dynavax Technologies Corporation Follicular Lymphoma Treatment Product
Table 110. Dynavax Technologies Corporation Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 111. Dynavax Technologies Corporation Recent Development
Table 112. Eisai Company Details
Table 113. Eisai Business Overview
Table 114. Eisai Follicular Lymphoma Treatment Product
Table 115. Eisai Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Eisai Recent Development
Table 117. EpiZyme, Inc. Company Details
Table 118. EpiZyme, Inc. Business Overview
Table 119. EpiZyme, Inc. Follicular Lymphoma Treatment Product
Table 120. EpiZyme, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 121. EpiZyme, Inc. Recent Development
Table 122. F. Hoffmann-La Roche Ltd. Company Details
Table 123. F. Hoffmann-La Roche Ltd. Business Overview
Table 124. F. Hoffmann-La Roche Ltd. Follicular Lymphoma Treatment Product
Table 125. F. Hoffmann-La Roche Ltd. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 126. F. Hoffmann-La Roche Ltd. Recent Development
Table 127. Genentech, Inc. Company Details
Table 128. Genentech, Inc. Business Overview
Table 129. Genentech, Inc. Follicular Lymphoma Treatment Product
Table 130. Genentech, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 131. Genentech, Inc. Recent Development
Table 132. Gilead Sciences, Inc. Company Details
Table 133. Gilead Sciences, Inc. Business Overview
Table 134. Gilead Sciences, Inc. Follicular Lymphoma Treatment Product
Table 135. Gilead Sciences, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 136. Gilead Sciences, Inc. Recent Development
Table 137. GlaxoSmithKline Plc Company Details
Table 138. GlaxoSmithKline Plc Business Overview
Table 139. GlaxoSmithKline Plc Follicular Lymphoma Treatment Product
Table 140. GlaxoSmithKline Plc Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 141. GlaxoSmithKline Plc Recent Development
Table 142. Hutchison MediPharma Limited Company Details
Table 143. Hutchison MediPharma Limited Business Overview
Table 144. Hutchison MediPharma Limited Follicular Lymphoma Treatment Product
Table 145. Hutchison MediPharma Limited Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 146. Hutchison MediPharma Limited Recent Development
Table 147. Immune Design Corp. Company Details
Table 148. Immune Design Corp. Business Overview
Table 149. Immune Design Corp. Follicular Lymphoma Treatment Product
Table 150. Immune Design Corp. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 151. Immune Design Corp. Recent Development
Table 152. ImmunoGen, Inc. Company Details
Table 153. ImmunoGen, Inc. Business Overview
Table 154. ImmunoGen, Inc. Follicular Lymphoma Treatment Product
Table 155. ImmunoGen, Inc. Revenue in Follicular Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 156. ImmunoGen, Inc. Recent Development
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Follicular Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Stem Cell Transplantation Features
Figure 6. Global Follicular Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Follicular Lymphoma Treatment Report Years Considered
Figure 11. Global Follicular Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Follicular Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Follicular Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Follicular Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 15. Global Follicular Lymphoma Treatment Market Share by Players in 2020
Figure 16. Global Top Follicular Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Follicular Lymphoma Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Follicular Lymphoma Treatment Revenue in 2020
Figure 18. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Follicular Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 22. North America Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 23. North America Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 24. United States Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 28. Europe Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 29. Europe Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 30. Germany Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Follicular Lymphoma Treatment Market Share by Region (2016-2027)
Figure 40. China Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Follicular Lymphoma Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Follicular Lymphoma Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Follicular Lymphoma Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Follicular Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
  • Global Centralized Patient Monitoring System Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 130
    According to this latest study, the 2020 growth of Centralized Patient Monitoring System will have significant change from previous year. By the most conservative estimates of global Centralized Patient Monitoring System market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 490.5 million in 2019. Over the next five years the Centralized Patient Monitoring System market will register a 6.3% CAGR in terms of revenue, the global market size will rea......
  • Global Livestock Animal Vaccines Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 159
    According to this latest study, the 2020 growth of Livestock Animal Vaccines will have significant change from previous year. By the most conservative estimates of global Livestock Animal Vaccines market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 4632.4 million in 2019. Over the next five years the Livestock Animal Vaccines market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 5868.7 million by 2025.......
  • Global Clinical Reference Laboratory Services Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Clinical Reference Laboratory Services will have significant change from previous year. By the most conservative estimates of global Clinical Reference Laboratory Services market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 11450 million in 2019. Over the next five years the Clinical Reference Laboratory Services market will register a 5.4% CAGR in terms of revenue, the global market size will ......
  • Global Steam Chemical Indicator Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 139
    According to this latest study, the 2020 growth of Steam Chemical Indicator will have significant change from previous year. By the most conservative estimates of global Steam Chemical Indicator market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 105.9 million in 2019. Over the next five years the Steam Chemical Indicator market will register a 6.7% CAGR in terms of revenue, the global market size will reach US$ 137.2 million by 2025. ......
  • Global Oral Guided Bone Regeneration (GTR) Membrane Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 167
    According to this latest study, the 2020 growth of Oral Guided Bone Regeneration (GTR) Membrane will have significant change from previous year. By the most conservative estimates of global Oral Guided Bone Regeneration (GTR) Membrane market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 201.6 million in 2019. Over the next five years the Oral Guided Bone Regeneration (GTR) Membrane market will register a 6.6% CAGR in terms of revenue, the global......
  • Global Non-Wearable Sleep Tracker Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 137
    According to this latest study, the 2020 growth of Non-Wearable Sleep Tracker will have significant change from previous year. By the most conservative estimates of global Non-Wearable Sleep Tracker market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 250.4 million in 2019. Over the next five years the Non-Wearable Sleep Tracker market will register a 13.7% CAGR in terms of revenue, the global market size will reach US$ 418.6 million by 2025.......
  • Global Hematopoietic Stem Cells Transplantation Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 119
    According to this latest study, the 2020 growth of Hematopoietic Stem Cells Transplantation will have significant change from previous year. By the most conservative estimates of global Hematopoietic Stem Cells Transplantation market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2110.6 million in 2019. Over the next five years the Hematopoietic Stem Cells Transplantation market will register a 5.9% CAGR in terms of revenue, the global market siz......
  • Global Non-invasive Glucose Monitoring Device Market Growth 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 132
    According to this latest study, the 2020 growth of Non-invasive Glucose Monitoring Device will have significant change from previous year. By the most conservative estimates of global Non-invasive Glucose Monitoring Device market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 2974.9 million in 2019. Over the next five years the Non-invasive Glucose Monitoring Device market will register a 26.7% CAGR in terms of revenue, the global market size wil......
  • Global Veterinary Rapid Test Market Growth (Status and Outlook) 2021-2026
    Published: 22-Jan-2021        Price: US 3660 Onwards        Pages: 131
    According to this latest study, the 2020 growth of Veterinary Rapid Test will have significant change from previous year. By the most conservative estimates of global Veterinary Rapid Test market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 493.7 million in 2019. Over the next five years the Veterinary Rapid Test market will register a 8.8% CAGR in terms of revenue, the global market size will reach US$ 692.3 million by 2025. Thi......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs